These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9409387

  • 1. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
    Blake G, Murphy S.
    Neurology; 1997 Dec; 49(6):1747-8. PubMed ID: 9409387
    [No Abstract] [Full Text] [Related]

  • 2. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.
    Webster GF, Knobler RL, Lublin FD, Kramer EM, Hochman LR.
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728
    [Abstract] [Full Text] [Related]

  • 3. Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.
    Longthorne PN.
    BMJ; 1996 Nov 16; 313(7067):1263. PubMed ID: 8939141
    [No Abstract] [Full Text] [Related]

  • 4. Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.
    Cardy P.
    BMJ; 1996 Nov 16; 313(7067):1263. PubMed ID: 8939142
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of multiple sclerosis with interferon beta-1 b.
    Abdul-Ahad A, Shah S, Galazka A.
    Neurology; 1997 Aug 16; 49(2):641-2. PubMed ID: 9270626
    [No Abstract] [Full Text] [Related]

  • 6. Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.
    Chellingsworth M.
    BMJ; 1996 Nov 16; 313(7067):1263. PubMed ID: 8939140
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b.
    Schwid SR, Goodman AD, Mattson DH.
    Arch Neurol; 1997 Sep 16; 54(9):1169-90. PubMed ID: 9311363
    [Abstract] [Full Text] [Related]

  • 11. [Immunotherapy of multiple sclerosis. Consensus and controversies].
    Hohlfeld R.
    Nervenarzt; 1999 Apr 16; 70(4):297. PubMed ID: 10354989
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment.
    Dionisiotis J, Zoukos Y, Thomaides T.
    J Neurol Neurosurg Psychiatry; 2004 Jul 16; 75(7):1079. PubMed ID: 15201386
    [No Abstract] [Full Text] [Related]

  • 14. Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.
    O'Sullivan SS, Cronin EM, Sweeney BJ, Bourke JF, Fitzgibbon J.
    J Neurol Neurosurg Psychiatry; 2006 Dec 16; 77(12):1382-3. PubMed ID: 16782776
    [No Abstract] [Full Text] [Related]

  • 15. Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.
    Christopher V, Scolding N, Przemioslo RT.
    J Neurol; 2005 Jul 16; 252(7):855-6. PubMed ID: 15742101
    [No Abstract] [Full Text] [Related]

  • 16. Lethal capillary leak syndrome after a single administration of interferon beta-1b.
    Niederwieser G.
    Neurology; 2000 Apr 11; 54(7):1545-6. PubMed ID: 10751284
    [No Abstract] [Full Text] [Related]

  • 17. New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson.
    Alsalameh S, Manger B, Kern P, Kalden J.
    Arthritis Rheum; 1998 Apr 11; 41(4):754. PubMed ID: 9550494
    [No Abstract] [Full Text] [Related]

  • 18. Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a.
    Tola MR, Caniatti LM, Gragnaniello D, Russo M, Stabellini N, Granieri E.
    J Neurol; 2003 Jun 11; 250(6):768-9. PubMed ID: 12862038
    [No Abstract] [Full Text] [Related]

  • 19. An open-labelled assessment of adverse effects associated with interferon 1-beta in the treatment of multiple sclerosis.
    Logan-Clubb L, Stacy M.
    J Neurosci Nurs; 1995 Dec 11; 27(6):344-7. PubMed ID: 8770778
    [Abstract] [Full Text] [Related]

  • 20. Meningioma growth during interferon beta-1A treatment for multiple sclerosis.
    Gama HP, Rocha AJ, Silva CJ, Mendes MF, Veiga JC, Lancellotti CL, Andrade VP, Tilbery CP.
    Arq Neuropsiquiatr; 2008 Jun 11; 66(2B):402-4. PubMed ID: 18641881
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.